CD40-activated macrophages could potentially mediate tumor cell death by expressing TRAIL, although no evidence for TRAIL was found in a study of B16 melanoma treated with agonistic anti-CD40 antibody plus CpG [59]. This evidence concerns the gene TNFSF10 and melanoma.